![]() |
市場調查報告書
商品編碼
1818044
全球健康專用穿戴裝置和醫療用電子設備市場:預測至 2032 年 - 按產品類型、使用案例、分銷管道、應用和地區進行分析Health-Focused Wearables & Medical Electronics Market Forecasts to 2032 - Global Analysis By Product Type, Use Case, Distribution Channel, Application and By Geography |
根據 Stratistics MRC 的數據,全球健康專用穿戴和醫療用電子設備市場預計在 2025 年達到 207 億美元,到 2032 年將達到 367 億美元,預測期內的複合年成長率為 8.5%。
健康專用穿戴式醫療用電子設備是專門設計用於透過與人體進行持續、非侵入式互動來監測、診斷和支持生理功能的設備。這些系統整合了感測器、微處理器和無線連接,可即時追蹤生命徵象、活動水平和生物特徵數據。它們常用於慢性病管理、健身和遠距患者照護,從而增強個人化醫療服務的提供。這些技術著重準確性、舒適性和資料安全性,有助於預防性護理、早期療育和改善臨床療效。
根據《自然電子》報道,2021年全球穿戴式醫療設備市場規模將超過200億美元,其中心臟監測和血糖追蹤佔臨床級穿戴裝置的60%以上。
遠端患者監護(RPM) 和遠端醫療的轉變
穿戴式生物感測器和互聯醫療用電子設備如今能夠持續追蹤生命徵象,指導臨床醫生早期療育並制定個人化治療方案。與雲端基礎平台和人工智慧主導的分析技術的整合正在提高診斷準確性並降低醫院再入院率。隨著醫療保健系統轉向分散式護理,可互通、以患者為中心的設備的需求正在加速成長。主要市場的報銷改革和數位基礎設施升級也為這一轉變提供了支持。
電池壽命限制
持續的數據傳輸、即時監控和先進的感測器功能對緊湊的外形規格提出了巨大的能耗要求。頻繁充電會降低可用性,尤其對於老年人和行動不便的使用者而言。此外,儘管製造商正在探索低功耗晶片組和能源採集技術,但擴充性和成本效益仍然是一個難題。在電池壽命顯著提升之前,在高度依賴的臨床環境中,該設備的採用可能會受到限制。
擴展到臨床級設備
經FDA或CE認證的設備在醫院居家照護、術後照護和慢性病監測領域日益普及。生物訊號保真度、多參數感測和安全資料傳輸方面的創新,使穿戴式裝置能夠滿足嚴格的臨床檢驗標準。新興企業和成熟企業都在投資將生活方式追蹤與診斷級效能相結合的混合平台。這一發展預計將開闢新的報銷途徑,並擴大遠距離診斷的覆蓋範圍。
消費者冷漠,留存率低
許多用戶放棄設備的原因包括缺乏感知價值、用戶介面設計不良或數據疲勞。如果沒有有效的回饋迴路或與照護路徑的整合,穿戴式裝置可能會淪為一種新鮮玩意。此外,隱私問題以及與電子健康記錄(EHR) 有限的互通性也阻礙了使用者的持續使用。品牌必須優先考慮行為科學主導的設計和個人化洞察,以提高用戶留存率。如果無法解決這些問題,消費級市場可能會陷入停滯。
疫情推動了遠距離診斷和健康監測解決方案的需求激增,刺激了穿戴式醫療用電子設備的快速創新。醫療機構關閉和醫療系統人滿為患,促使患者尋求面對面諮詢的替代方案,從而推動了遠端醫療和遠距醫療監測(RPM)的普及。配備脈動式血氧監測儀系統、心電圖感測器和體溫監測器的穿戴式設備已成為早期症狀檢測和新冠疫情後復健追蹤的重要工具。然而,供應鏈中斷和半導體短缺暫時阻礙了生產和分銷。
診斷和監測設備領域預計將成為預測期內最大的市場
診斷和監測設備領域預計將在預測期內佔據最大的市場佔有率,這得益於其在慢性病管理和預防性醫療保健中的關鍵作用。智慧型貼片、穿戴式心電圖監測儀和連網血壓監測儀等設備正擴大應用於臨床工作流程和家庭環境。它們能夠為醫療保健提供者提供即時數據,從而提高治療準確性並減少緊急干預。人工智慧診斷和雲端基礎平台的興起進一步增強了該領域的相關性。
預計消費級設備領域在預測期內的複合年成長率最高
受健康意識不斷提升和生活方式追蹤趨勢的推動,消費級設備領域預計將在預測期內實現最高成長率。健身手環、配備健康感測器的智慧型手錶以及睡眠監測器等產品在年輕且注重健康的用戶中越來越受歡迎。與行動應用程式和遊戲化健康平台的整合正在提升用戶參與度。此外,健康與臨床效用之間界線的模糊也迫使製造商提高感測器的精度和數據可靠性。
在預測期內,北美預計將佔據最大的市場佔有率,這得益於其先進的醫療基礎設施和數位醫療技術的廣泛應用。該地區受益於強大的報銷框架、積極的監管支持以及蓬勃發展的醫療技術創新者生態系統。科技巨頭與醫療服務提供者之間的策略夥伴關係正在加速產品開發和部署。此外,慢性病盛行率的上升和人口老化也刺激了持續監測解決方案的需求。
在預測期內,亞太地區預計將實現最高的複合年成長率,這得益於醫療保健涵蓋範圍的擴大、可支配收入的增加以及預防性醫療保健意識的不斷增強。中國、印度和韓國等國家正見證穿戴式裝置在健康和臨床應用領域的快速普及。政府主導的數位醫療和本地製造措施正在進一步刺激市場成長。該地區人口眾多,智慧型手機普及率高,使其成為可擴展穿戴式裝置(RPM)解決方案的理想沃土。
According to Stratistics MRC, the Global Health-Focused Wearables & Medical Electronics Market is accounted for $20.7 billion in 2025 and is expected to reach $36.7 billion by 2032 growing at a CAGR of 8.5% during the forecast period. Health-focused wearables and medical electronics are specialized devices designed to monitor, diagnose, or support physiological functions through continuous, non-invasive interaction with the human body. These systems integrate sensors, microprocessors, and wireless connectivity to track vital signs, activity levels, and biometric data in real time. Commonly used in chronic disease management, fitness, and remote patient care, they enhance personalized healthcare delivery. Emphasizing accuracy, comfort, and data security, these technologies contribute to preventive medicine, early intervention, and improved clinical outcomes.
According to Nature Electronics, the global market for wearable medical devices surpassed $20 billion in 2021, with cardiac monitoring and glucose tracking accounting for over 60% of clinical-grade wearable deployments.
Shift to remote patient monitoring (RPM) and telemedicine
Wearable biosensors and connected medical electronics now enable continuous tracking of vital signs, empowering clinicians to intervene early and personalize treatment plans. Integration with cloud-based platforms and AI-driven analytics is enhancing diagnostic accuracy and reducing hospital readmission rates. As healthcare systems pivot toward decentralized care, demand for interoperable, patient-centric devices is accelerating. This shift is also supported by reimbursement reforms and digital infrastructure upgrades across key markets.
Limited battery life
Continuous data transmission, real-time monitoring, and advanced sensor functionalities place high energy demands on compact form factors. Frequent recharging disrupts usability, particularly for elderly or mobility-impaired users. Moreover, manufacturers are exploring low-power chipsets and energy harvesting technologies, but scalability and cost-efficiency remain hurdles. Until battery longevity improves significantly, device adoption may be constrained in high-dependency clinical settings.
Expansion into clinical-grade devices
Devices capable of FDA or CE certification are gaining traction in hospital-at-home programs, post-operative care, and chronic disease monitoring. Innovations in biosignal fidelity, multi-parameter sensing, and secure data transmission are enabling wearables to meet stringent clinical validation standards. Startups and incumbents alike are investing in hybrid platforms that combine lifestyle tracking with diagnostic-grade performance. This evolution is expected to unlock new reimbursement pathways and broaden the scope of remote diagnostics.
Consumer apathy and low retention rates
Many users abandon devices due to lack of perceived value, poor user interface design, or data fatigue. Without meaningful feedback loops or integration into care pathways, wearables risk becoming novelty items. Additionally, privacy concerns and limited interoperability with electronic health records (EHRs) deter sustained use. Brands must prioritize behavioral science-driven design and personalized insights to improve retention. Failure to address these issues could lead to stagnation in consumer-grade segments.
The pandemic catalyzed a surge in demand for remote diagnostics and health monitoring solutions, driving rapid innovation in wearable medical electronics. Lockdowns and overwhelmed healthcare systems prompted patients to seek alternatives to in-person consultations, boosting telemedicine and RPM adoption. Wearables equipped with pulse oximeters, ECG sensors, and temperature monitors became essential tools for early symptom detection and post-COVID recovery tracking. However, supply chain disruptions and semiconductor shortages temporarily hindered production and distribution.
The diagnostic & monitoring devices segment is expected to be the largest during the forecast period
The diagnostic & monitoring devices segment is expected to account for the largest market share during the forecast period due to its critical role in chronic disease management and preventive care. Devices such as smart patches, wearable ECG monitors, and connected blood pressure cuffs are increasingly used in clinical workflows and home settings. Their ability to deliver real-time data to healthcare providers enhances treatment precision and reduces emergency interventions. The proliferation of AI-enabled diagnostics and cloud-based platforms further strengthens the segment's relevance.
The consumer-grade devices segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the consumer-grade devices segment is predicted to witness the highest growth rate driven by rising health consciousness and lifestyle tracking trends. Products like fitness bands, smartwatches with health sensors, and sleep monitors are gaining popularity among younger demographics and wellness-focused users. Integration with mobile apps and gamified health platforms is boosting user engagement. Moreover, the blurring lines between wellness and clinical utility are prompting manufacturers to enhance sensor accuracy and data reliability.
During the forecast period, the North America region is expected to hold the largest market share propelled by its advanced healthcare infrastructure and high adoption of digital health technologies. The region benefits from strong reimbursement frameworks, active regulatory support, and a thriving ecosystem of medtech innovators. Strategic partnerships between tech giants and healthcare providers are accelerating product development and deployment. Additionally, rising prevalence of chronic conditions and aging populations are fueling demand for continuous monitoring solutions.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by expanding healthcare access, rising disposable incomes, and growing awareness of preventive health. Countries like China, India, and South Korea are witnessing rapid adoption of wearables for both wellness and clinical applications. Government-led initiatives promoting digital health and local manufacturing are further stimulating market growth. The region's large population base and increasing smartphone penetration create fertile ground for scalable RPM solutions.
Key players in the market
Some of the key players in Health-Focused Wearables & Medical Electronics Market include Meta Platforms, Inc., Apple Inc., Sony Corporation, HTC Corporation, Lenovo Group Ltd., Microsoft Corporation, Google LLC, Samsung Electronics Co., Ltd., XREAL, Viture, Pico Interactive, Magic Leap, Inc., Vuzix Corporation, Varjo Technologies, RealWear, Inc., Rokid, Epson America, Inc., Goertek, HP Inc. and RayNeo.
In August 2025, HTC unveiled the VIVE Eagle AI glasses, a consumer-focused AI eyewear product with bundled AI services. The release positions VIVE Eagle as HTC's move into lightweight AI eyewear and consumer AR experiences.
In June 2025, Apple announced expanded Apple Intelligence features, developer tools, and a new universal "liquid glass" software design. Apple positioned these updates as enabling private, on-device AI and richer UX across iPhone, iPad, Mac and Vision Pro.
In June 2025, XREAL announced collaborations and distributor agreements at CES 2025 and rolled product updates (One Pro availability) through mid-2025. The company highlighted expanding global availability and modular camera/feature upgrades for its AR glasses.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.